Sign in Subscribe
Cancer research

Modulation of RIP1 Ubiquitylation and Distribution Senses Cancer Cells to TNF-alpha-Induced Apoptosis

Strategic Insights

— 1 min read

Research from Japan has shed light on a new mechanism by which certain small molecules, represented by MeBS, sensitize cancer cells to apoptosis (programmed cell death). The study, led by S. Kim and colleagues from the National Institute of Health Science, found that MeBS modulates the ubiquitylation and distribution of RIP1, a protein that plays a crucial role in apoptosis. By reducing the ubiquitylated form of RIP1 and increasing its non-ubiquitylated form, MeBS enhances the effectiveness of tumor necrosis factor-alpha (TNF-alpha) in inducing apoptosis in cancer cells.

Key Takeaways:

  • MeBS sensitizes cancer cells to apoptosis by modulating RIP1 ubiquitylation and distribution.
  • RIP1, a protein ubiquitylated by cIAP1, plays a significant role in apoptosis, particularly in response to TNF-alpha stimulation.
  • MeBS reduces the ubiquitylated form of RIP1 in the TNF-receptor complex, while increasing its non-ubiquitylated form bound to caspase-8.
  • Downregulation of RIP1 by siRNA reduces apoptosis induced by TNFa plus MeBS treatment.
  • The study highlights the importance of RIP1 in apoptosis induced by combined treatment with TNFa and MeBS.
  • This research suggests that MeBS could be a potential adjunct therapy to TNF-alpha treatment for cancer.

Statistics:

  • 4 types of cancer (esophageal squamous cell carcinoma, hepatocellular carcinoma, cervical cancer, and lung cancer) show genetic amplification of anti-apoptosis protein cIAP1 (Kim et al., 2010).
  • MeBS activates auto-ubiquitylation of cIAP1 for proteasomal degradation, leading to apoptosis of various cancer cells (prev. reported).
  • The study reports a significant decrease in ubiquitylated RIP1 in the TNF-receptor complex and a corresponding increase in non-ubiquitylated RIP1 bound to caspase-8 upon MeBS treatment.
  • siRNA-mediated downregulation of RIP1 reduces apoptosis induced by TNFa plus MeBS treatment by 50% (Kim et al., 2010).

Sources:

  • Kim, S., et al. (2010). Modulation of RIP1 ubiquitylation and distribution by MeBS to sensitize cancer cells to tumor necrosis factor alpha-induced apoptosis. Cancer Science, 101(11), 2425-2429.
  • Graduate School, National Institute of Health Science
  • Cancer Science, 2010, Volume 101, Issue 11, Pages 2425-2429
  • Biotech Week editors from staff and other reports, 2010.

Read more